3-12516627-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP5BS1_Supporting
The NM_025265.4(TSEN2):āc.926A>Gā(p.Tyr309Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000502 in 1,613,986 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_025265.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSEN2 | NM_025265.4 | c.926A>G | p.Tyr309Cys | missense_variant | Exon 7 of 12 | ENST00000284995.11 | NP_079541.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152028Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000139 AC: 35AN: 251398Hom.: 1 AF XY: 0.000103 AC XY: 14AN XY: 135876
GnomAD4 exome AF: 0.0000534 AC: 78AN: 1461842Hom.: 1 Cov.: 31 AF XY: 0.0000605 AC XY: 44AN XY: 727220
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152144Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74380
ClinVar
Submissions by phenotype
Pontocerebellar hypoplasia type 2B Pathogenic:3Other:1
- -
- -
- -
- -
not provided Uncertain:2
This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 309 of the TSEN2 protein (p.Tyr309Cys). This variant is present in population databases (rs113994149, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with pontocerebellar hypoplasias (PMID: 18711368, 20952379). ClinVar contains an entry for this variant (Variation ID: 2125). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Observed with a second TSEN2 variant in a patient with pontocerebellar hypoplasia, but it is not known whether the variants occurred on the same (in cis) or on different (in trans) chromosomes (PMID: 20952379); Published functional studies suggest Y309C affects thermal stability (PMID: 34584079); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 20952379, 18711368, 34584079, 38347586) -
Pontoneocerebellar hypoplasia Pathogenic:1
Variant summary: TSEN2 c.926A>G (p.Tyr309Cys) results in a non-conservative amino acid change located in the tRNA intron endonuclease, N-terminal domain (IPR006678) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. Multiple sequence alignment of human TSEN2 with the corresponding sequences of a broad range of other organisms showed that the Tyr309 position is strictly conserved (tyrosine or phenylalanine) within eukaryotic organisms (Budde_2008). The variant allele was found at a frequency of 0.00014 in 251398 control chromosomes in the gnomAD database, including 1 homozygote. This frequency is not significantly higher than estimated for a pathogenic variant in TSEN2 causing Pontocerebellar Hypoplasia, Type 2B (0.00014 vs 0.0011), allowing no conclusion about variant significance. Moreover, the single homozygote observed in gnomAD database has been reported as not a true homozygote due to one read supporting a reference base (Tarailo-Graovac_2017). c.926A>G has been reported in the literature as a homozygous and compound heterozygous genotype in individuals affected with Pontocerebellar Hypoplasia, Type 2B (example, Budde_2008, Namavar_2011). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as pathogenic and one laboratory classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at